AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

University Health Network

🇨🇦Canada

Country: 🇨🇦Canada

Ownership: Private

Established: 1999-01-01

Employees: 10K

Market Cap: -

Website: http://www.uhn.ca

Clinical Trials

Patient Centred Communication Intervention

Not Applicable

Completed

Conditions: Aphasia
Stroke

Interventions: Behavioral: Patient-Centred Communication Intervention

First Posted Date: 2012-07-31

Last Posted Date: 2014-04-24

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 120

Registration Number: NCT01654029

Locations: 🇨🇦
Toronto Rehabilitation Institute, E.W. Bickle Centre, Toronto, Ontario, Canada

Evaluation of a 'Hand-held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (JDRTC/UHN)

Conditions: Diabetic Foot Ulcers
Wounds

First Posted Date: 2012-07-27

Last Posted Date: 2018-02-14

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 80

Registration Number: NCT01651845

Locations: 🇨🇦
University Health Network - Judy Dan Research and Treatment Centre, Toronto, Ontario, Canada

Evaluation of a 'Hand-Held' Fluorescence Digital Imaging Device for Real-Time Advanced Wound Care Monitoring (SMH/UHN)

Completed

Conditions: Surgical Wounds

First Posted Date: 2012-07-26

Last Posted Date: 2017-08-28

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 7

Registration Number: NCT01650571

Locations: 🇨🇦
St. Michael's Hospital, Toronto, Ontario, Canada

Intra Cranial EEG Activity During Dexmedetomidine Sedation

Terminated

Conditions: Complex Partial Seizures

First Posted Date: 2012-07-25

Last Posted Date: 2022-12-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 5

Registration Number: NCT01648959

Locations: 🇨🇦
Toronto Western Hospital,UHN., Toronto, Ontario, Canada

Effect of Electrical Muscle Stimulation in Critically Ill Patients

Phase 1

Completed

Conditions: Critical Illness

Interventions: Other: Sham EMS
Other: Electrical muscle stimulation (EMS)

First Posted Date: 2012-07-11

Last Posted Date: 2016-02-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT01637467

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Effect of Sumatriptan on the Postoperative Quality of Recovery After Elective Minimally Invasive Craniotomy

Not Applicable

Completed

Conditions: Postoperative Quality of Recovery
Postoperative Migrainous Headache

Interventions: Drug: Sumatriptan
Other: Placebo

First Posted Date: 2012-07-03

Last Posted Date: 2022-12-22

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 40

Registration Number: NCT01632657

Locations: 🇨🇦
Toronto Western Hospital, Toronto, Ontario, Canada

Paclitaxel Eluting Balloon for SFA In-stent Restenosis

Not Applicable

Conditions: In-stent Arterial Restenosis

Interventions: Device: PTA with drug eluting balloon with paclitaxel

First Posted Date: 2012-06-12

Last Posted Date: 2014-12-09

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 30

Registration Number: NCT01616888

Locations: 🇨🇦
University Health Network, Toronto, Ontario, Canada

Pharmacokinetics of Tranexamic Acid in Patients With Varying Renal Function Undergoing Cardiac Surgery With the Use of Cardiopulmonary Bypass

Completed

Conditions: Renal Disease
Cardiac Disease

First Posted Date: 2012-06-01

Last Posted Date: 2017-02-03

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 49

Registration Number: NCT01609686

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Measurement of Extravascular Lung Water to Detect and Predict Primary Graft Dysfunction Following Lung Transplant

Conditions: Primary Graft Dysfunction

First Posted Date: 2012-05-24

Last Posted Date: 2018-01-19

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 60

Registration Number: NCT01605214

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Sitagliptin Regulation of Intestinal and Hepatic Lipoprotein Particle and Hepatic Glucose Production in Humans

Phase 2

Completed

Conditions: Hyperlipidemia

Interventions: Drug: Placebo
Drug: Sitagliptin

First Posted Date: 2012-05-17

Last Posted Date: 2017-01-23

Lead Sponsor: University Health Network, Toronto

Target Recruit Count: 21

Registration Number: NCT01600703

Locations: 🇨🇦
Toronto General Hospital, Toronto, Ontario, Canada

Home Terms & Conditions Privacy Policy